首页> 外文期刊>Biomedical Engineering Letters >Focused ultrasound treatment for central nervous system disease: neurosurgeon’s perspectives
【24h】

Focused ultrasound treatment for central nervous system disease: neurosurgeon’s perspectives

机译:集中的超声治疗中枢神经系统疾病:神经外科医生的观点

获取原文
获取原文并翻译 | 示例
       

摘要

The concept of focused ultrasound (FUS) and its application in the field of medicine have been suggested since the mid-20th century. However, the clinical applications of this technique in central nervous system (CNS) diseases have been extremely limited because the skull inhibits efficient energy transmission. Therefore, early application of FUS treatment was only performed in patients who had already undergone invasive procedures including craniectomy and burr hole trephination. In the 1990s, the phased array technique was developed and this enabled the focus of ultrasonic energy through the skull, and in conjunction with another technique, magnetic resonance thermal monitoring, the possibility of applying FUS in the CNS was further strengthened. The first clinical trial using FUS treatment for CNS diseases was performed in the early 21st century in patients with glioblastoma, which consists of highly malignant primary brain tumors. However, this trial resulted in a failure to make lesions in the tumors. Various causes were suggested for this outcome including different acoustic impedances across heterogeneous intracranial tissue (not only brain tissue, but also fibrous or tumor tissue). To avoid the influence of this factor, the targets for FUS treatment were shifted to functional diseases such as essential tremor, Parkinson’s disease, and psychiatric disease, which usually occur in normal brain structures. The first trial for functional diseases was started in 2010, and the results were successful as accurate lesions were made in the target area. Nowadays, the indication of FUS treatment for functional CNS diseases is gradually widening, and many trials using the FUS technique are reporting good results. In addition to the lesioning technique using high intensity FUS treatment, the possibility of clinical application of low intensity FUS to CNS disease treatment has been investigated at a preclinical level, and it is expected that FUS treatment will become one of the most important novel techniques for the treatment of CNS diseases in the near future.
机译:自20世纪中叶以来,已经提出了聚焦超声(FUS)及其在医学领域的应用。然而,这种技术在中枢神经系统(CNS)疾病中的临床应用极为有限,因为颅骨抑制了有效的能量传输。因此,早期应用Fus治疗仅在已经经历了侵入性手术的患者中进行,包括颅骨切除术和毛刺孔曲线。在20世纪90年代,开发了分阶段阵列技术,这使得通过颅骨使超声波能量的焦点能够进一步加强磁共振热监测,进一步加强了在CNS中施加FU的可能性。使用FUS治疗CNS疾病的第一个临床试验在21世纪初期进行了胶质母细胞瘤的患者,这包括高度恶性的原发性脑肿瘤。然而,该试验导致肿瘤中的病变失败。提出了这种结果的各种原因,包括跨均相颅内组织(不仅脑组织,也纤维或肿瘤组织)的不同声学阻抗。为了避免这种因素的影响,Fus治疗的目标被转移到功能疾病,如必要的震颤,帕金森病和精神病疾病,这通常发生在正常的脑结构中。第一次试验在2010年开始,结果是成功的,因为在目标区域进行了准确的病变。如今,功能性CNS疾病的Fus治疗指示逐渐加宽,并且使用FUS技术的许多试验报告了良好的结果。除了使用高强度Fus治疗的病变技术外,还在临床前水平研究了低强度FU对CNS病理治疗的临床应用的可能性,预计FUS治疗将成为最重要的新技术之一在不久的将来治疗CNS疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号